Tender Details
Ref No 25487847
Document

Tender Notice

Bidding

Not specified

Short Description

Provision Of Trauma Therapy And Clinical Supervisor Services
Deadline *
Date 31 Mar 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Canada
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 9840495
  • Location: Finland

Dps Housing Support Services For Disabled Persons Offers By 22 November 2024 At 11 00

  • Deadline: 30 Nov 2033
  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026

Consultancy Services Information Security

  • Deadline: 01 Nov 2028
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 5310892
  • Location: Germany

Drug Contracts With An Option To Join

  • Deadline: 01 May 2026
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027

Technical Testing And Analysis Services Other Not Included In Other Groups

  • Deadline: 24 May 2105
  • Ref No: 5396790
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L

  • Deadline: 27 Apr 2026
  • Ref No: 4687154
  • Location: Germany

Building Cleaning Maintenance And Basic Cleaning

  • Deadline: 31 Dec 2037
  • Ref No: 5837008
  • Location: Ireland

Establishment Of Five Panels For The Provision Of Emergency Accommodation For The Drhe

  • Deadline: 16 May 2026
  • Ref No: 5226107
  • Location: Germany

Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08

  • Deadline: 31 Mar 2026
  • Ref No: 5976401
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

  • Deadline: 10 May 2026
  • Ref No: 5965319
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medi

  • Deadline: 10 May 2026
  • Ref No: 5968352
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage

  • Deadline: 10 May 2026
WhatsApp Chat